Since we excluded participants with heavy alcohol intake, chronic viral hepatitis, and rare forms of chronic liver disease (autoimmune, metabolic, or toxic liver disease), we expect NAFLD to be the cause of elevated ALT levels in most of our study participants. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.